Jay Lawrence Goodman, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated October 24, 2024, indicates that Goodman does not beneficially own any non-derivative or derivative securities of the company. The form, signed on October 29, 2024, is a standard disclosure for individuals in Goodman's position, indicating transparency in ownership and potential changes in control or influence over the company.

Jay Lawrence Goodman, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated October 24, 2024, indicates that Goodman does not beneficially own any non-derivative or derivative securities of the company. The form, signed on October 29, 2024, is a standard disclosure for individuals in Goodman's position, indicating transparency in ownership and potential changes in control or influence over the company.